A Prospective Phase II Study of Brachytherapy in Men with Prostate Cancer that Returned after Prior External Beam Radiation Therapy
[Protocol 12-098] |
Kollmeier, Marisa |
- Prostate Cancer
- Localized Disease
- Rising PSA After Primary Therapy
|
A Phase I Dose-Escalation Study of Image-Guided Radiation Therapy for Bladder Cancer Patients Undergoing Radiotherapy and Concurrent Gemcitabine Chemotherapy
[Protocol 10-031] |
Kollmeier, Marisa |
|
A Phase I Study of AGS-22M6E in Patients with Malignant Solid Tumors Expressing Nectin-4
[Protocol 11-113] |
Konner, Jason |
|
A Phase II Study of Intrathecal I131-3F8 in Patients with GD2-Expressing Central Nervous System and Leptomeningeal Neoplasms
[Protocol 05-122] |
Kramer, Kim |
- Brain Tumors, Metastatic
- Brain Tumors, Primary
- Neuroblastoma
- Pediatric Brain Tumors
|
A Study of Vorinostat (SAHA) plus Isotretinoin and Chemotherapy in Infants and Young Children with Embryonal Tumors of the Central Nervous System
[Protocol 12-191] |
Kramer, Kim |
|
A Phase I Study of Intrathecal Radioimmunotherapy Using 131I-8H9 for Central Nervous System/Leptomeningeal Cancers
[Protocol 03-133] |
Kramer, Kim |
- Brain Tumors, Primary
- Neuroblastoma
- Pediatric Brain Tumors
|
A Phase II Study of WT-1 Analog Peptide Vaccine in Patients with Malignant Pleural Mesothelioma
[Protocol 10-134] |
Krug, Lee |
|
A Phase II Toxicity Study Using Chemotherapy Followed By Intensity Modulated Radiation Therapy to the Pleura in Patients with Locally Advanced Unresectable Malignant Pleural Mesothelioma
[Protocol 08-053] |
Krug, Lee |
|
A Phase II Study of Ipilimumab versus Standard Chemotherapy after Initial Therapy in Patients with Inoperable or Advanced Gastric or Gastroesophageal Cancer
[Protocol 12-277] |
Ku, Geoffrey |
- Upper Gastrointestinal
- Esophageal Cancer
- Gastric Cancer
|
Memorial Sloan-Kettering Cancer Center Pancreatic Tumor Registry
[Protocol 02-102] |
Kurtz, Robert |
- Hepatobiliary
- Hereditary Cancer & Genetics
- Upper Gastrointestinal
|
A Phase I Study of the Hu3F8 Antibody plus GM-CSF in Patients with Relapsed/Refractory Neuroblastoma
[Protocol 12-230] |
Kushner, Brian |
|
A Phase II Study of High-Dose 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Primary Refractory Neuroblastoma in the Bone Marrow
[Protocol 09-161] |
Kushner, Brian |
|
A Phase II Study of High-Dose 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of Second or Greater Remission of High-Risk Neuroblastoma
[Protocol 09-160] |
Kushner, Brian |
|
A Phase II Study of High-Dose 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of First Remission after Non-Myeloablative Therapy in Patients with High-Risk Neuroblastoma
[Protocol 09-159] |
Kushner, Brian |
|
A Phase I Trial of a Trivalent Vaccine with Escalating Doses of the Immunological Adjuvant OPT-821 Plus Oral ß-Glucan for High-Risk Neuroblastoma
[Protocol 05-075] |
Kushner, Brian |
|
A Phase I Study of Topical Calcitriol (Compound 31543) to Prevent Hair Loss in Women Receiving Paclitaxel for Advanced Breast Cancer
[Protocol 11-205] |
Lacouture, Mario |
|
A Phase III Study of Hormone Therapy with and without Chemotherapy in Patients with HER2-Negative Breast Cancer and 1-3 Positive Lymph Nodes and a Recurrence Score of 25 or Less
[Protocol 12-118] |
Lake, Diana |
|
A Trial of Single Autologous Transplant with or without Consolidation Therapy versus Tandem Autologous Transplant with Lenalidomide Maintenance for Patients with Multiple Myeloma
[Protocol 09-171] |
Landau, Heather |
- Blood & Marrow Stem Cell Transplantation
- Autologous
- Sibling and Unrelated Volunteer
- Blood and Marrow Transplantation
- Hematology
|
A Phase I/II Study of AT7519M with and without Bortezomib in Patients with Previously Treated Multiple Myeloma
[Protocol 10-151] |
Landau, Heather |
|
A Phase II Study of Bendamustine and Dexamethasone in Patients with Relapsed Amyloidosis
[Protocol 12-257] |
Landau, Heather |
|
